InChI=1S/C22H30O4/c1- 5- 6- 7- 8- 14- 12- 17- 19(20(23) 18(14) 21(24) 25) 15- 11- 13(2) 9- 10- 16(15) 22(3,4) 26- 17/h11- 12,15- 16,23H,5- 10H2,1- 4H3,(H,24,25) /t15- ,16- /m1/s1 |
UCONUSSAWGCZMV-HZPDHXFCSA-N |
[H][C@@]12CCC(C)=C[C@@]1([H])c1c(O)c(C(O)=O)c(CCCCC)cc1OC2(C)C |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via phytocannabinoid )
cannabinoid receptor agonist
An agonist that binds to and activates cannabinoid receptors.
(via cannabinoid )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
biomarker
A substance used as an indicator of a biological state.
|
|
View more via ChEBI Ontology
(6aR,10aR)- 1- hydroxy- 6,6,9- trimethyl- 3- pentyl- 6a,7,8,10a- tetrahydro- 6H- benzo[c]chromene- 2- carboxylic acid
|
9-Carboxy-delta(9)-thc
|
ChemIDplus
|
9-Carboxy-thc
|
ChemIDplus
|
delta(9)-Tetrahydrocannabinolic acid
|
ChemIDplus
|
1397267
|
Reaxys Registry Number
|
Reaxys
|
23978-85-0
|
CAS Registry Number
|
ChemIDplus
|
15190053
|
PubMed citation
|
Europe PMC
|
16511162
|
PubMed citation
|
Europe PMC
|
|